Jump Financial’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,199
Closed -$258K 2300
2025
Q4
$258K Buy
+8,199
New +$272K ﹤0.01% 1626
2025
Q3
Sell
-5,356
Closed -$309K 2128
2025
Q2
$309K Sell
5,356
-110,078
-95% -$6.22M ﹤0.01% 1409
2025
Q1
$6.73M Buy
115,434
+65,569
+131% +$4.48M 0.09% 273
2024
Q4
$4.02M Buy
49,865
+37,935
+318% +$3.24M 0.08% 315
2024
Q3
$956K Buy
+11,930
New +$848K 0.02% 817
2024
Q2
Sell
-8,284
Closed -$409K 2160
2024
Q1
$409K Buy
8,284
+3,484
+73% +$166K 0.01% 1291
2023
Q4
$201K Buy
+4,800
New +$163K 0.01% 1563
2023
Q2
Sell
-13,400
Closed -$381K 2087
2023
Q1
$381K Buy
+13,400
New +$473K 0.02% 1010
2022
Q1
Sell
-29,692
Closed -$743K 1831
2021
Q4
$743K Buy
+29,692
New +$1.1M 0.05% 489

Other funds holding PRCT

Jump Financial's PRCT Position: Q1 2026 in Review

Jump Financial sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 8,199 shares — an estimated $258K sold.

Jump Financial first reported a position in PRCT in Q4 2021 and held it in 9 quarters. The position peaked at $6.73M in Q1 2025. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Jump Financial reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 8,199 Procept Biorobotics shares in Q1 2026, an estimated $258K.
  • Jump Financial first reported a position in Procept Biorobotics in Q4 2021 and held it in 9 quarters.
  • Jump Financial's Procept Biorobotics position peaked at $6.73M in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.